Report of the results of the 24 classifiers when using the 5-Protein biomarker.

<p>Removing IL-6 from the biomarker set we have a small gain in predicting AD in both data set, if compared to the 6-protein signature. In this case, the prediction of AD on the “AD” test set achieves an average of 96% without dropping the accuracy of the prediction of NonAD.